Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.

Summary

Novartis has made a competitive move in a multibillion-dollar drug race with potential implications for Eli Lilly. The article headline suggests market competition dynamics but lacks specific details about drugs, trial data, or financial information.